REGENXBIO Inc. (RGNX)
NASDAQ: RGNX
· Real-Time Price · USD
9.01
0.47 (5.50%)
At close: May 29, 2025, 3:59 PM
8.79
-2.44%
After-hours: May 29, 2025, 05:55 PM EDT
REGENXBIO Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| License and Service Revenue | 83.33M | 90.24M | 112.72M |
| License and Service Revenue Growth | -7.66% | -19.94% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 20.35M | 20.05M | 19.42M | 18.86M | 18.29M | 19.08M | 23.08M | 23.7M | 22.63M | 21.21M | 20.92M | 20.83M | 22.32M | 22.04M | 21.03M | 18.43M | 17.84M | 17.57M | 15.86M | 15.55M | 14.83M | 14.45M | 12.4M | 13.4M | 11.56M | 11.14M | 9.01M | 8.32M | 8.38M | 4.81M | 9.44M | 6.36M | 6.62M | 5.74M | 6.2M | 6.17M | 5.48M | 4.23M | 2.57M | 3.4M | 1.72M |
| Selling, General, and Administrative Revenue Growth | +1.48% | +3.24% | +3.01% | +3.08% | -4.13% | -17.35% | -2.60% | +4.70% | +6.71% | +1.38% | +0.43% | -6.66% | +1.26% | +4.80% | +14.14% | +3.29% | +1.52% | +10.80% | +1.96% | +4.86% | +2.65% | +16.51% | -7.48% | +15.98% | +3.72% | +23.71% | +8.30% | -0.74% | +74.29% | -49.09% | +48.61% | -4.03% | +15.33% | -7.39% | +0.50% | +12.59% | +29.47% | +64.86% | -24.43% | +97.96% | n/a |
| Research and Development Revenue | 53.09M | 50.38M | 54.43M | 44.82M | 50.66M | 51.35M | 58.18M | 59.89M | 58.52M | 62.51M | 63.31M | 61.01M | 55.63M | 47.98M | 47.85M | 45.88M | 39.72M | 47.18M | 43.97M | 38.11M | 37.03M | 33.81M | 35.69M | 29.48M | 25.2M | 24.33M | 18.51M | 21.49M | 19.55M | 14.17M | 12.52M | 13.92M | 16.62M | 16.06M | 12.56M | 10.68M | 6.18M | 4.81M | 5.66M | 4.01M | 2.79M |
| Research and Development Revenue Growth | +5.37% | -7.44% | +21.44% | -11.54% | -1.33% | -11.75% | -2.84% | +2.34% | -6.38% | -1.28% | +3.78% | +9.67% | +15.94% | +0.26% | +4.30% | +15.51% | -15.81% | +7.31% | +15.37% | +2.91% | +9.55% | -5.28% | +21.06% | +16.98% | +3.59% | +31.45% | -13.86% | +9.90% | +37.97% | +13.20% | -10.05% | -16.26% | +3.49% | +27.86% | +17.60% | +72.73% | +28.49% | -15.04% | +41.18% | +43.75% | n/a |